| Literature DB >> 27732638 |
Gamze Isitman1,2, Alexandra Tremblay-McLean1,2, Irene Lisovsky1,2, Julie Bruneau3,4, Bertrand Lebouché1,5,6, Jean-Pierre Routy1,2,5,7, Nicole F Bernard1,2,5,8.
Abstract
Natural Killer (NK) cell education, which requires the engagement of inhibitory NK cell receptors (iNKRs) by their ligands, is important for generating self-tolerant functional NK cells. While the potency of NK cell education is directly related to their functional potential upon stimulation with HLA null cells, the influence of NK cell education on the potency of the antibody dependent cellular cytotoxicity (ADCC) function of NK cells is unclear. ADCC occurs when the Fc portion of an immunoglobulin G antibody bridges the CD16 Fc receptor on NK cells and antigen on target cells, resulting in NK cell activation, cytotoxic granule release, and target cell lysis. We previously reported that education via the KIR3DL1/HLA-Bw4 iNKR/HLA ligand combination supported higher KIR3DL1+ than KIR3DL1- NK cell activation levels but had no impact on ADCC potency measured as the frequency of granzyme B positive (%GrB+) targets generated in an ADCC GranToxiLux assay. A lower frequency of KIR3DL1+ compared to KIR3DL1- NK cells were CD16+, which may in part explain the discrepancy between NK cell activation and target cell effects. Here, we investigated the frequency of CD16+ cells among NK cells expressing other iNKRs. We found that CD16+ cells were significantly more frequent among NK cells negative for the inhibitory KIR (iKIR) KIR2DL1, KIR2DL3, and KIR3DL1 than those positive for any one of these iKIR to the exclusion of the others, making iKIR+ NK cells poorer ADCC effectors than iKIR- NK cells. The education status of these iKIR+ populations had no effect on the frequency of CD16+ cells.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27732638 PMCID: PMC5061331 DOI: 10.1371/journal.pone.0164517
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Study population HLA and KIR genotypes.
| Donor | 3DL1/S1 | 2DL1 | 2DL3 | HLA-A | HLA-B | HLA-C | Bw4 | C1/C2 |
|---|---|---|---|---|---|---|---|---|
| 1 | 3DL1 | 1 | 1 | 01:01, 03:01 | 44:03, 49 | 07:01, 16:01 | 1 | C1 |
| 2 | 3DL1 | 1 | 1 | 24:01, 26:01 | 15:01, 57:01 | 05:01, 06:02 | 1 | C2 |
| 3 | HTZ | 1 | 0 | 03:01, 32:01 | 13:02, 53:01 | 04:01, 06:02 | 1 | C2 |
| 4 | 3DL1 | 1 | 1 | 01:01, 31:01 | 49:01 | 07:01 | 1 | C1 |
| 5 | 3DL1 | 1 | 1 | 02:01, 03:01 | 07:02, 27:05 | 01:02, 07:02 | 1 | C1 |
| 6 | 3DS1 | 1 | 1 | 02:01, 24:02 | 38:01, 78:01 | 07:02 | 1 | C1 |
| 7 | 3DL1 | 1 | 1 | 02:01 | 07:02, 57:01 | 05:01, 06:02 | 1 | C2 |
| 8 | HTZ | 1 | 1 | 03:01, 11:01 | 40, 57:01 | 02:02, 04:01 | 1 | C2 |
| 9 | 3DL1 | 1 | 1 | 01:01, 23:01 | 14:02, 38:01 | 08:02, 12:02 | 1 | C1 |
| 10 | HTZ | 1 | 0 | 02:01, 29:02 | 07:02, 44:03 | 07:02,16:01 | 1 | C1 |
| 11 | 3DS1 | 1 | 1 | 02:01, 03:01 | 27:05, 47:01 | 02:02, 06:02 | 1 | C2 |
| 12 | HTZ | 1 | 1 | 02:01, 03:01 | 07:02, 50:01 | 07:02, 16:02 | 0 | C1 |
| 13 | 3DL1 | 1 | 1 | 01:01, 02:01 | 08:01, 40:01 | 03:02, 07:01 | 0 | C1 |
| 14 | 3DL1 | 1 | 1 | 02:01 | 07:02, 08:01 | 07:01, 07:02 | 0 | C1 |
| 15 | 3DL1 | 1 | 1 | 02:01, 30:02 | 07:02, 35:01 | 04:01, 07:02 | 0 | C1/C2 |
| 16 | 3DL1 | 1 | 1 | 03:01, 11:01 | 07:02, 35:01 | 04:01, 07:02 | 0 | C1/C2 |
| 17 | 3DL1 | 1 | 1 | 02:01, 24:02 | 44:02, 01:01 | 05:01, 08:02 | 1 | C1/C2 |
| 18 | 3DL1 | 1 | 1 | 01:01, 26:01 | 38:01, 57:01 | 06:02, 12:03 | 1 | C1/C2 |
| 19 | HTZ | 1 | 1 | 01:01, 23:01 | 44:03, 57:01 | 04:01, 06:02 | 1 | C2 |
| 20 | HTZ | 1 | 1 | 11:01, 24:02 | 27:02, 53:03 | 02:02, 04:01 | 1 | C2 |
| 21 | HTZ | 1 | 0 | 02:01, 11:01 | 35:01, 40:02 | 02:02, 04:01 | 0 | C2 |
| 22 | 3DL1 | 1 | 1 | 01:01, 68:02 | 18:01, 57:01 | 05:01, 06:02 | 1 | C1/C2 |
| 23 | 3DL1 | 1 | 1 | 02:01, 03:01 | 35:01, 40:01 | 03:04, 04:01 | 0 | C1/C2 |
| 24 | 3DL1 | 1 | 1 | 02:01, 03:01 | 07:02, 08:01 | 07:01, 16:01 | 0 | C1 |
| 25 | 3DL1 | 1 | 1 | 01:01, 24:02 | 51:01, 73:01 | 04:01, 07:01 | 1 | C1/C2 |
| 26 | 3DL1 | 1 | 1 | 02:01, 25:01 | 18:01, 55:01 | 03:03, 12:03 | 0 | C1 |
1 KIR3DL1 generic genotype, 3DL1 = KIR3DL1 homozygote, HTZ = KIR3DL1/S1 heterozygote, 3DS1 = KIR3DS1 homozygotes.
2 0 = not present; 1 = present.
Fig 1Frequency of CD16+, NKG2A+ and CD57+ NK cells and their subsets expressing or not CD16.
(A) Representative gating strategy for determining the frequency of CD16+/- cells on CD56total, CD56dim, and CD56bright NK cell populations and on the NKG2A-/+ and CD57-/+ subsets of these populations. (B) Frequencies of CD16+/- cells in the CD56total, CD56dim, and CD56bright NK cell populations. Frequencies of expression of NKG2A (C) and CD57 (E) on CD56total, CD56dim, and CD56bright NK cells. A Friedman test was used to assess the significance of matched between group differences. Frequencies of CD16+ and CD16- cells within the NKG2A+ (D) and CD57+ (F) CD56total, CD56dim, and CD56bright NK cell populations. Each data point represents results for 1 of 26 separate individuals. Bar height and error bars represent the median and interquartile range for the data set. Wilcoxon tests were used to determine significance of within subject differences for the indicated NK subsets linked by a line connecting the data sets. Significant values are shown; “*” = p< 0.05; “**” = p< 0.01; “***” = p< 0.001; “****” = p< 0.0001.
Fig 2CD16 expression on total CD56+ NK cells populations expressing all combinations of iKIRs and on CD56dim single iNKR expressing NK cell populations.
(A) The frequency of KIR+ (expressing any Boolean combination of KIR2DL1 (2DL1), KIR2DL3 (2DL3), or KIR3DL1 (3DL1]) subsets in CD16- and CD16+ total CD56+ NK cell populations. (B) The gating strategy for assessing the frequencies of single NKG2A, 2DL1, 2DL3, and 3DL1 and CD16 positive CD56dim NK cells. (C) Frequencies of CD16 positive CD56dim NK cells that are single positive for NKG2A (n = 26), 2DL1 (n = 25),2DL3 (n = 22), and 3DL1 (n = 22) or negative for all iNKR tested (iNKR-). Wilcoxon tests were used to determine significance of within subject differences for the indicated NK subsets. Each data point represents results a separate individual. Bar height and error bars represent the median and interquartile range for the data set. Significant values are shown; “**” = p< 0.01; “***” = p< 0.001; “****” = p< 0.0001.
Fig 3The frequency of educated and uneducated CD56dim NK cell populations expressing CD16 and one of the inhibitory KIR KIR2DL1, KIR2DL3, or KIR3DL1.
The frequency of CD16+ cells among educated KIR2DL1+ (2DL1) NKG2A-CD56dim NK cells from HLA-C2 homozygotes (n = 8) versus uneducated HLA-C1 homozygotes (n = 11), educated KIR2DL3+ (2DL3) NKG2A-CD56dim NK cells from HLA-C1 homozygotes (n = 10) versus uneducated HLA-C2 homozygotes (n = 7), and educated KIR3DL1+ (3DL1) NKG2A-CD56dim NK cells from Bw4 carriers (n = 8) versus uneducated Bw6 homozygotes (n = 8). The lines and error bars through the datasets represent medians and interquartile ranges. Mann-Whitney tests assessing the significance of differences in the frequency of CD16+, single KIR positive cells in educated versus uneducated NK cell subsets found no significant differences.